Phase I Study of Clofarabine and 2-Gy Total Body Irradiation as a Nonmyeloablative Preparative Regimen for Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia Consortium Study
Sandeep Soni(Lucile Packard Children's Hospital), Haydar Frangoul(Children’s Hospital at TriStar Centennial), Meghann McManus(Primary Children's Hospital), Richard Sposto(Children's Hospital of Los Angeles), Hisham Abdel‐Azim(University of Southern California), Ann E. Woolfrey(University of Washington), Eneida R. Nemecek(Oregon Health & Science University)
Cited by 9
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
|New England Journal of Medicine|2020|1.8k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
The treatment of medulloblastoma
|Journal of neurosurgery|1990|583
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577